Ping Yang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Coronavirus Disease

Top Venues

Medical review (2021)

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Liming Liao, Ping Yang, Weilong Zhang, Shuyu Yu, Hong-Mei Jing, Xiaofeng Zheng
CD98hc promotes drug resistance in extranodal natural killer/T cell lymphoma through tumor cell-derived small extracellular vesicles. Science signaling 17 (853) (2024)
Wei Liu, Ping Yang, Ping Yang, Li Yang, Hongmei Jing, Li-Bo Zhao, Rongsheng Zhao
Clinical characteristics and pharmacokinetics of PAXLOVID in COVID-19 patients with hematological tumor. Medical review (2021) 4 (2) (2024)
Wei Liu, Ping Yang, Ping Yang, Li Yang, Hongmei Jing, Li-Bo Zhao, Rongsheng Zhao
Clinical characteristics and pharmacokinetics of PAXLOVID in COVID-19 patients with hematological tumor. Medical review (2021) 4 (2) (2024)